Insider Transactions in Q3 2024 at Castle Biosciences Inc (CSTL)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 16
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
3,155
-3.05%
|
$94,650
$30.97 P/Share
|
|
Sep 16
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
1,972
-2.02%
|
$59,160
$30.97 P/Share
|
|
Sep 11
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
1,620
-1.57%
|
$48,600
$30.32 P/Share
|
|
Sep 11
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
996
-1.01%
|
$29,880
$30.32 P/Share
|
|
Sep 09
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
1,590
-1.48%
|
$46,110
$29.46 P/Share
|
|
Sep 09
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
996
-1.0%
|
$28,884
$29.46 P/Share
|
|
Sep 05
2024
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
7,867
-16.67%
|
$228,143
$29.02 P/Share
|
|
Sep 04
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
500
-0.47%
|
$15,000
$30.02 P/Share
|
|
Sep 04
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
298
-0.3%
|
$8,940
$30.02 P/Share
|
|
Sep 03
2024
|
Kristen M Oelschlager Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,832
-2.09%
|
$169,128
$29.49 P/Share
|
|
Sep 03
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
699
-0.66%
|
$20,970
$30.05 P/Share
|
|
Sep 03
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
417
-0.42%
|
$12,510
$30.05 P/Share
|
|
Aug 30
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
539
-0.5%
|
$16,170
$30.1 P/Share
|
|
Aug 30
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
322
-0.32%
|
$9,660
$30.1 P/Share
|
|
Aug 29
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
2,246
-2.04%
|
$67,380
$30.07 P/Share
|
|
Aug 29
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
1,334
-1.31%
|
$40,020
$30.07 P/Share
|
|
Aug 26
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
128
-0.12%
|
$3,840
$30.05 P/Share
|
|
Aug 26
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
76
-0.07%
|
$2,280
$30.05 P/Share
|
|
Aug 23
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
1,746
-1.56%
|
$52,380
$30.09 P/Share
|
|
Aug 23
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
1,037
-1.01%
|
$31,110
$30.09 P/Share
|
|
Aug 12
2024
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
7,883
-14.32%
|
$204,958
$26.65 P/Share
|
|
Aug 09
2024
|
Kristen M Oelschlager Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,804
-1.95%
|
$72,904
$26.83 P/Share
|
|
Aug 09
2024
|
Kristen M Oelschlager Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,641
+6.9%
|
-
|
|
Aug 09
2024
|
Tobin W Juvenal Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,592
-4.41%
|
$67,392
$26.83 P/Share
|
|
Aug 09
2024
|
Tobin W Juvenal Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,641
+15.33%
|
-
|
|
Aug 09
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
21,828
-17.48%
|
$567,528
$26.83 P/Share
|
|
Aug 09
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
66,991
+34.91%
|
-
|
|
Aug 09
2024
|
Frank Stokes Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,822
-6.96%
|
$73,372
$26.83 P/Share
|
|
Aug 09
2024
|
Frank Stokes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,745
+19.37%
|
-
|
|
Aug 07
2024
|
Frank Stokes Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-13.09%
|
$250,000
$25.67 P/Share
|
|
Aug 01
2024
|
Kristen M Oelschlager Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
12,989
-4.55%
|
$298,747
$23.24 P/Share
|
|
Jul 29
2024
|
Kristen M Oelschlager Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,793
-1.88%
|
$61,446
$22.06 P/Share
|
|
Jul 14
2024
|
Ellen Goldberg Director |
BUY
Exercise of conversion of derivative security
|
Direct |
440
+2.31%
|
-
|
|
Jul 14
2024
|
Kim Caple Director |
BUY
Exercise of conversion of derivative security
|
Direct |
440
+3.09%
|
-
|
|
Jul 01
2024
|
Kristen M Oelschlager Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,793
-1.84%
|
$58,653
$21.22 P/Share
|
|
Jul 01
2024
|
Tiffany Olson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
830
+4.6%
|
-
|